Hospital
HCH Tucson Holdings LLC
HCH Tucson Holdings LLC was paid $240K by Medicaid between Oct 2019 and Sep 2022, across 44 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoHCH TUCSON HOLDINGS LLC
NOGALES, AZ 85621
NOGALES, AZ 85621
33aNPI1255707873assigned 08/18/2015
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$240K
24GClaims2,817
24DCodes billed44
24AFirst – last monthOct 2019 – Sep 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 552 | $36K | |
| 2022 | 2,265 | $205K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 145 | 142 | $80K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 166 | 159 | $60K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.5% | 75 | 71 | $23K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.1% | 16 | 14 | $22K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.2% | 320 | 92 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.1% | 65 | 57 | $15K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3.5% | 121 | 42 | $8K |
| 97162 | <1% | 12 | 12 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | 12 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 75 | 72 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 29 | 13 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 51 | 49 | $1K |
32 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 65 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 19 | $875.51 |
| 74018 | <1% | 12 | $526.28 | |
| 87186 | <1% | 30 | $55.72 | |
| 80053 | Comprehensive metabolic panel | <1% | 204 | $52.99 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 250 | $36.76 |
| 81001 | <1% | 155 | $3.55 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 55 | $0.00 |
| 81025 | 0% | 30 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 20 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 60 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 69 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 15 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 12 | $0.00 |
| 87077 | 0% | 33 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 12 | $0.00 |
| 97014 | 0% | 36 | $0.00 | |
| 83690 | 0% | 71 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 14 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 67 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 83 | $0.00 |
| 87088 | 0% | 62 | $0.00 | |
| 84484 | 0% | 40 | $0.00 | |
| 83605 | 0% | 39 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 82 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 85 | $0.00 |
| 83735 | 0% | 13 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 13 | $0.00 |
| 84703 | 0% | 23 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 32 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIAL, JODY (CFO)
Parent organizationHCH TUCSON HOLDINGS LLC
| Provider | Location | Paid |
|---|---|---|
| HCH Tucson Holdings LLC | Nogales, AZ | $40.95M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.